CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹25,644 Cr | ₹21,439 Cr | ₹18,057 Cr | ₹15,669 Cr | ₹13,537 Cr |
What is the latest Profit & Loss Account Balance ratio of CIPLA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹25,644 Cr |
| Mar2024 | ₹21,439 Cr |
| Mar2023 | ₹18,057 Cr |
| Mar2022 | ₹15,669 Cr |
| Mar2021 | ₹13,537 Cr |
How is Profit & Loss Account Balance of CIPLA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,644 Cr | 19.62 | |
| Mar2024 | ₹21,439 Cr | 18.73 | |
| Mar2023 | ₹18,057 Cr | 15.24 | |
| Mar2022 | ₹15,669 Cr | 15.75 | |
| Mar2021 | ₹13,537 Cr | - | |
Compare Profit & Loss Account Balance of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,352.9 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹95,809.4 Cr | -5.6% | 2.9% | -2.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.6% |
5.6% |
-5.7% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses